The Gambia is currently observing a female mortality from cvd, cancer, diabetes or crd between exact ages 30 and 70 of 20%, marking a decrease of 0.1% (-0.5%) compared to 2018.
Female mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 in the Gambia
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2019
Points:
13,760
Measure:
%
Similar regions to the Gambia
Female CVD, cancer, diabetes or CRD
More indicators for the Gambia
Out-of-pocket expenditure PPP per capita
intl dollar15
+intl dollar1
(2021)
Newborns protected against tetanus
96%
+1%
(2022)
Female wasting in children
4.1%
-1.5%
(2020)
Birth registration
59%
+1.1%
(2020)
Female prevalence of HIV
0.4%
0%
(2022)
Contraceptive modern method prevalence
17.1%
+0.8%
(2020)
Gambia Female CVD, cancer, diabetes or CRD between 2000 and 2019
Period | Female CVD, cancer, diabetes or CRD | Change |
---|---|---|
2019 | 20% | -0.1% |
2018 | 20.1% | -0.1% |
2017 | 20.2% | -0.1% |
2016 | 20.3% | -0.2% |
2015 | 20.5% | -0.3% |
2014 | 20.8% | +0.1% |
2013 | 20.7% | +0.1% |
2012 | 20.6% | +0.3% |
2011 | 20.3% | +0.1% |
2010 | 20.2% | -0.2% |
2009 | 20.4% | -0.1% |
2008 | 20.5% | -0.1% |
2007 | 20.6% | 0% |
2006 | 20.6% | +0.1% |
2005 | 20.5% | 0% |
2004 | 20.5% | +0.3% |
2003 | 20.2% | +0.2% |
2002 | 20% | +0.2% |
2001 | 19.8% | +0.1% |
2000 | 19.7% |